Kara Palamountain
Kara Palamountain

Research Associate Professor within Kellogg's Public-Private Interface Initiative
Lecturer of Global Health

Print Overview

Kara Palamountain is a Research Associate Professor at the Kellogg School of Management and a Lecturer of Global Health.

Ms. Palamountain has managed over 50 Kellogg field research teams conducting market entry analysis for medical technologies in over a dozen countries (Botswana, Brazil, Cambodia, China, India, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Tanzania, Uganda, Vietnam and Zambia).

In July 2017, the MacArthur Foundation named an internal team of collaborators, including Ms. Palamountain, as a finalist in the 100&Change $100M grant competition for their plan to develop and implement Newborn Essential Solutions and Technologies, or NEST 360, which is an integrated group of 17 lifesaving technologies that could reduce newborn deaths by half in Africa. Ms. Palamountain has also served as an external reviewer for various projects under consideration by the Bill & Melinda Gates Foundation and a peer reviewer for Grand Challenges Canada. She also authored "Exploring the Case for a Global Alliance for Medical Diagnostics Initiaitive" published in Diagnostics, "Perspectives On Introduction And Implementation Of New Point-Of-Care Diagnostic Tests" and "Opportunities And Challenges For Cost-Efficient Implementation Of New Point-Of-Care Diagnostics For HIV And Tuberculosis" published in the Journal of Infectious Diseases, and "Optimizing tuberculosis case detection through a novel diagnostic device placement model: The case of Uganda".

Ms. Palamountain is also the President of the Northwestern Global Health Foundation. Prior to her work at the Northwestern Global Health Foundation and at Kellogg, Kara worked as a management consultant in Deloitte's Healthcare practice for over six years (1998-2002; 2004-2006). She received her MBA from Kellogg in 2004 and her BBA from the University of Texas at Austin in 1998.

Areas of Expertise
International Healthcare

Print Vita
MBA, 2004, Kellogg School of Management, Northwestern University
BBA, 1998, Marketing and Business Honors Program, University of Texas at Austin

Academic Positions
Lecturer of International Business & Markets, Kellogg School of Management, Northwestern University, 2006-present
Executive Director of the Kellogg Global Health Initiative, Kellogg School of Management, Northwestern University, 2006-present
Research Assistant Professor, Kellogg School of Management, Northwestern University, 2006-present

Other Professional Experience
President, Northwestern Global Health Foundation, 2010-present
Senior Consultant, Deloitte Consulting, 2004-2006
Manager, Deloitte Consulting, 2004-2006
HIV/AIDS Initiatives Summer Intern, Abbott Laboratories, 2003-2003
Consultant, Deloitte Consulting, 1999-2002
Business Analyst, Deloitte Consulting, 1998-1999

Editorial Positions
Editorial Board, Global Health Innovation, 2018

Print Research
Palamountain, Kara and Jim Gallarda. 2017. Exploring the Case for a Global Alliance for Medical Diagnostics Initiative. Diagnostics. 7(1): 8.
Palamountain, Kara and David Maman. 2015. Sustainable HIV treatment in Africa through viral-load-informed differentiated care.. NATURE. 528(7580)
Palamountain, Kara, Wendy S. Stevens, David Kelso and Mark Fisher. 2015. An investigation of fingerstick blood collection for point-of-care. South African Medical Journal. 105(3): 228-231.
Palamountain, Kara. 2015. Optimizing tuberculosis case detection through a novel diagnostic device placement model: The case of Uganda. PLoS ONE.(10(4): e0122574)
Pai, M. and Kara Palamountain. 2012. New tuberculosis technologies challenges for retooling and scale-up. International Journal of Tuberculosis and Lung Disease. 16(10): 1281-1290.
Palamountain, Kara, Jeff Baker, Elliot P. Cowan, Shaffiq Essajee, Laura T. Mazzola, Mutsumi Metzler, Marco L. Schito, Wendy S. Stevens, Gloria J. Young and Gonzalo J. Domingo. 2012. Perspectives on Introduction and Implementation of New Point-of-Care Diagnostic Tests. The Journal of Infectious Diseases.
Schito, Marco L., Trevor F. Peter, Sean Cavanaugh, Amy S. Piatek, Gloria J. Young, Heather Alexander, William Coggin, Gonzalo J. Domingo, Dennis Ellenberger, Eugen Ermantraut, Ilesh V. Jani, Achilles Katamba, Kara Palamountain, Shaffiq Essajee and David W. Dowdy. 2012. Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis.. The Journal of Infectious Diseases. jis044v2-jis044
Palamountain, Kara and A. Nabatiyan. 2011. Towards the development of point-of-care diagnostics for global health needs. Clinical Laboratory International.
Diermeier, Daniel, Kara Palamountain, Annette Krauss, Kearsley A. Stewart and David Kelso. 2010. University leadership for innovation in global health and HIV/AIDS diagnostics. Global Public Health. 5(2): 189-196.
Working Papers
Palamountain, Kara, Kearsley A. Stewart, Daniel Diermeier, Annette Krauss and David Kelso. 2009. Triangulation: A new model for innovation in Global Health and HIV/AIDS Diagnostics.
Palamountain, Kara and Timothy Calkins. 2017. Chlorhexidine Adoption in Nigeria. Case 5-217-255 (KE1028).
Palamountain, Kara, Sachin Waikar, Andrea Hanson and Katherine Nelson. 2008. Balancing Access with Accuracy for Infant HIV Diagnostics in Tanzania (A). Case 5-308-502(A) (KEL383).
Palamountain, Kara, Sachin Waikar, Andrea Hanson and Katherine Nelson. 2008. Balancing Access with Accuracy for Infant HIV Diagnostics in Tanzania (B). Case 5-308-502(B) (KEL384).
Calkins, TimothyKara Palamountain, Aniruddha Chatterjee, Robert Frantz, Elizabeth Hart, Sean Mathewson and Gabriela Perez-Hobrecker. 2015. Fighting Childhood Pneumonia in Uganda. Case 5-413-755 (KEL874).

Print Teaching
Full-Time / Evening & Weekend MBA
Social Innovation: Designing for Change (KPPI-452-0)
This course was formerly known as KIEI 452-0.
In this experiential lab course, students will explore - in class and through quarter-long consulting projects - innovation as a mechanism for social problem solving. The lab component of this course places teams of Kellogg students with a local organization that has an innovative product, service or business model. Teams will work with nonprofit organizations with revenue-generating initiatives and for-profit companies working in: education; energy & sustainability; financial services; healthcare; and housing & community development. This class will be beneficial for students who want to start, work for, advise or invest in a business with an innovation that is designed to have a social impact.

Field Study (KPPI-498-0)

Medical Technologies in Developing Countries (KPPI-973-5)

**This course was formerly listed as KPPI-973-A/KPPI-973-B**

Students who enroll in KPPI 973-5 in Winter Quarter will automatically be enrolled in KPPI 973-5 in Spring Quarter. Students will earn one credit and receive a grade at the end of Spring Quarter. The class meets during the final five weeks of Winter Quarter and the first five weeks of Spring Quarter and requires all students to participate in two weeks of in-country field work between the two quarters.

The Medical Technologies in Developing Countries course provides students the unique opportunity to inform the design and launch of medical technologies for developing countries by conducting in-country market research. The students' findings will be shared with the developers of the medical technologies, including Northwestern University and several companies and philanthropists.

Prior market research trips have taken place in India, Kenya, Mozambique, Tanzania, Uganda, Malawi and Zambia, each with a focus on medical technologies such as HIV tests, tuberculosis tests, and mobile health technologies for pediatric health.

Students will spend the second five weeks of Winter Quarter in the classroom learning the science of HIV/AIDS, tuberculosis, and other high-burden diseases; the background on medical technologies under development for these markets; the essentials for conducting medical product market research in these geographies; the basic economics, culture, and politics of the country of interest; and the fundamentals of the country's healthcare system. Following this initial coursework, students will spend two weeks on the ground understanding how the medical technologies are perceived by the key stakeholders in the market, including: end-users at hospitals and clinics, government officials, and NGOs and distributors. After the field work, students will then return for five weeks in the classroom in Spring Quarter where they will learn to analyze their field work, synthesize key findings and provide recommendations to the developers of these medical technologies.

**Admittance to this course is by application only.**
Your accepted application for this class will also ensure that you will be enrolled in KPPI-973-5 in Spring Quarter.

Students may not drop after the first week of the class.